Forecasting index of unfavorable outcomes of systemic lupus erythematosus

Aseeva E.A. Nikishina N.Yu. Mesnyankina A.A. Solovyev S.K. Isaeva B.Sh. Koilubaeva G.M. Lila A.M.
2021 Ima-Press Publishing House

Sovremennaya Revmatologiya
2021 #15 Issue 3 98 - 102 pp.

The development of irreversible organ damage (IOD) in systemic lupus erythematosus (SLE) significantly increases the risk of death, worsens the quality of life and significantly increases the cost of treatment. The development and implementation of specific tools that will promote early identification of the risk of unfavorable outcomes is a priority. The article presents literature review on a new method for prediction of unfavorable outcomes in SLE – frailty index (FI, vulnerability index). FI, developed by a group of international experts on the basis of the database of the international cohort of SLE patients – SLICC (Systemic Lupus International Collaborating Clinics) – is easily reproducible in real clinical practice and can be used in patients with an early stage of SLE to predict the risk of death, the development of IOD. and hospitalization. The SLE Forecasting index of unfavorable outcomes (SLICC-FI) appears to be a promising clinical and research tool for identifying those who need more careful monitoring and an individual therapeutic strategy at an early stage of the disease.

Frailty index , Systemic lupus erythematosus , Unfavorable outcomes

Text of the article Перейти на текст статьи

V.A. Nasonova Research Institute of Rheumatology, Moscow 34A, Kashirskoe Shosse, Moscow, 115522, Russian Federation
JSC Group of companies MEDSI, Moscow 3A, Gruzinskiy pereulok, Moscow, 123056, Russian Federation
Asfendiyarov Kazakh National Medical University, Almaty 94, Tole Bi Street, Almaty, 050000, Kazakhstan
Academician M. Mirrakhimov National Center for Cardiology and Therapy, Bishkek 3, Togolok Moldo St, Bishkek, 720040, Kyrgyzstan
Department of Rheumatology, Russian Medical Academy of Continuing Professional Education, Moscow 2/1, Barrikadnaya St., Build. 1, Moscow, 125993, Russian Federation

V.A. Nasonova Research Institute of Rheumatology
JSC Group of companies MEDSI
Asfendiyarov Kazakh National Medical University
Academician M. Mirrakhimov National Center for Cardiology and Therapy
Department of Rheumatology

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026